168 related articles for article (PubMed ID: 10488101)
1. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
Marchiò S; Primo L; Pagano M; Palestro G; Albini A; Veikkola T; Cascone I; Alitalo K; Bussolino F
J Biol Chem; 1999 Sep; 274(39):27617-22. PubMed ID: 10488101
[TBL] [Abstract][Full Text] [Related]
2. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.
Marconcini L; Marchio S; Morbidelli L; Cartocci E; Albini A; Ziche M; Bussolino F; Oliviero S
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9671-6. PubMed ID: 10449752
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
5. Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells.
Montaldo F; Maffé A; Morini M; Noonan D; Giordano S; Albini A; Prat M
J Cell Physiol; 2000 Aug; 184(2):246-54. PubMed ID: 10867650
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan.
Marchisone C; Del Grosso F; Masiello L; Prat M; Santi L; Noonan DM
Pathol Oncol Res; 2000; 6(1):10-7. PubMed ID: 10749582
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma.
Skobe M; Brown LF; Tognazzi K; Ganju RK; Dezube BJ; Alitalo K; Detmar M
J Invest Dermatol; 1999 Dec; 113(6):1047-53. PubMed ID: 10594750
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor C induces angiogenesis in vivo.
Cao Y; Linden P; Farnebo J; Cao R; Eriksson A; Kumar V; Qi JH; Claesson-Welsh L; Alitalo K
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14389-94. PubMed ID: 9826710
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.
Zeng H; Sanyal S; Mukhopadhyay D
J Biol Chem; 2001 Aug; 276(35):32714-9. PubMed ID: 11435426
[TBL] [Abstract][Full Text] [Related]
11. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
Bussolino F; Arese M; Montrucchio G; Barra L; Primo L; Benelli R; Sanavio F; Aglietta M; Ghigo D; Rola-Pleszczynski MR
J Clin Invest; 1995 Aug; 96(2):940-52. PubMed ID: 7543496
[TBL] [Abstract][Full Text] [Related]
12. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells.
Munshi N; Groopman JE; Gill PS; Ganju RK
J Immunol; 2000 Feb; 164(3):1169-74. PubMed ID: 10640727
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.
Masood R; Cai J; Zheng T; Smith DL; Naidu Y; Gill PS
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):979-84. PubMed ID: 9023368
[TBL] [Abstract][Full Text] [Related]
14. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
Marginean A; Sharma-Walia N
Transl Res; 2015 Aug; 166(2):111-33. PubMed ID: 25814167
[TBL] [Abstract][Full Text] [Related]
15. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo.
Masood R; McGarvey ME; Zheng T; Cai J; Arora N; Smith DL; Sloane N; Gill PS
Blood; 1999 Feb; 93(3):1038-44. PubMed ID: 9920854
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
